Montréal enSanté V8N4 Automne/Fall 2016 | Page 71
VACCINATION AGAINST HPV
COULD HAVE PREVENTED MY
CERVICAL
CANCER
Help protect yourself with
GARDASIL®9 if you’re a woman
between the ages of 9 and 45
• Cervical cancer is the 3rd most common cancer in Canadian women 20-40 years of age
• HPV is the leading cause of cervical cancer and genital warts
• It is estimated that 75% of sexually active Canadians will have at least one HPV
infection during their lifetime
Ask your healthcare professional about GARDASIL®9
GARDASIL9.ca
In girls and women ages 9 to 45, GARDASIL®9 helps protect against cervical, vaginal, and vulvar cancers caused by HPV types 16, 18, 31, 33,
45, 52 and 58, abnormal and precancerous vaginal and vulvar lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58, abnormal and
precancerous cervical lesions as found in a Pap test caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58, and genital warts caused by HPV
types 6 and 11. GARDASIL®9 does not treat HPV infection. GARDASIL®9 may not fully protect each person who gets it. GARDASIL®9 does not
remove the need for cervical cancer screening; women should still get routine cervical cancer screening. GARDASIL®9 is not recommended for
use in pregnant women. Like all vaccines, GARDASIL®9 may cause some side effects and allergic reactions. The most common side effects seen
with GARDASIL®9 are pain, swelling, redness, itching, bruising, bleeding, a lump where the shot is given, headache, fever, nausea, dizziness,
tiredness, diarrhea, abdominal pain and sore throat. Contact your doctor or healthcare professional to see if GARDASIL®9 is right for you.
HPV=human papillomavirus
Merck Sharp & Dohme Corp. Used under license.
© 2016 Merck Canada Inc. All rights reserved.
®